Concepedia

Author

Ralph Alderson

MacroGenics (United States)

Also Known As

RALPH ALDERSON, Ralph Alderson, Ralph F Alderson, Ralph F. Alderson

100

Publications

3.9K

Citations

20

H-Index

66

Concepts

All Affiliations

MacroGenics (United States)Regeneron (United States)Human Genome Sciences (United States)National Institutes of HealthNational Cancer Institute
RA

About

Ralph Alderson is an author at MacroGenics (United States) specializing in medicine, neuroscience, and neurophysiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

14

2.9K

2

Social Sciences

5

5

2.5K

3

Biochemistry

3

3

77

4

Health Sciences

2

2

187

5

Natural Sciences

2

2

66

Ralph Alderson

×

26

Publications

3.9K

Citations

20

H-Index

YearCitations

NT-3, BDNF, and NGF in the developing rat nervous system: Parallel as well as reciprocal patterns of expression

Peter C. Maisonpierre, Leonardo Belluscio, Beth Friedman,

Neuron

1990

1.2K

Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture

Ralph Alderson, Andrea L. Alterman, Yves‐Alain Barde,

Neuron

1990

689

Detection of brain-derived neurotrophic factor-like activity in fibroblasts and Schwann cells: Inhibition by antibodies to NGF

Ann Acheson, Philip Barker, Ralph Alderson,

Neuron

1991

284

Development of an Fc-Enhanced Anti–B7-H3 Monoclonal Antibody with Potent Antitumor Activity

Deryk Loo, Ralph Alderson, Francine Z. Chen,

Clinical Cancer Research

2012

270

Expression of Ciliary Neurotrophic Factor and the Neurotrophins – Nerve Growth Factor, Brain‐Derived Neurotrophic Factor and Neurotrophin 3—in Cultured Rat Hippocampal Astrocytes

John S. Rudge, Ralph Alderson, Elizabeth Pasnikowski,

European Journal of Neuroscience

1992

197

Differential distribution of exogenous BDNF, NGF, and NT‐3 in the brain corresponds to the relative abundance and distribution of high‐affinity and low‐affinity neurotrophin receptors

Ralph Alderson, C. Anthony Altar, Peter S. DiStefano,

The Journal of Comparative Neurology

1995

173

A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates

Gurunadh R. Chichili, Ling Huang, Hua Li,

Science Translational Medicine

2015

165

CAT-8015: A Second-Generation<i>Pseudomonas</i>Exotoxin A–Based Immunotherapy Targeting CD22-Expressing Hematologic Malignancies

Ralph Alderson, Robert J. Kreitman, Tianling Chen,

Clinical Cancer Research

2009

103

STRL22 Is a Receptor for the CC Chemokine MIP-3α

Fang Liao, Ralph Alderson, Jeffrey Su,

Biochemical and Biophysical Research Communications

1997

101

Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer

Adam Root, Wei Cao, Bilian Li,

Antibodies

2016

92

Page 1